Our data indicates the possibility that different isoforms or modified versions of SOX2 and NANOG may exist within different GBM tumors, and that a particular isoform present may influence tumor growth and tumor aggression in specific ways, although this remains a topic for further study. This evidence concerns the gene SOX2 and glioblastoma.